Section I
4521 – 4530 of 4905
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
(
- Contribution to journal › Article
- 1999
-
Mark
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
(
- Contribution to journal › Article
-
Mark
Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma
(
- Contribution to journal › Article
-
Mark
Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
(
- Contribution to journal › Article
-
Mark
Paragangliomas of the spinal canal
(
- Contribution to journal › Article
-
Mark
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer
(
- Contribution to journal › Article
-
Mark
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial
(
- Contribution to journal › Article
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Energy transfer between fluorescein isothiocyanate and propidium iodide--a problem in the estimation of Tpot with the bromodeoxyuridine-DNA flow cytometry technique?
(
- Contribution to journal › Article